David Busse (D Busse)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Bariatric Surgery

Top Venues

Antibiotics (Basel, Switzerland)

Journal of clinical medicine

Antimicrobial agents and chemotherapy

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

David Busse, P Simon, D Petroff, N El-Najjar, L Schmitt, D Bindellini, A Dietrich, Markus Zeitlinger, W Huisinga, Robin Michelet, H Wrigge, C Kloft
High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients. Antimicrobial agents and chemotherapy 66 (6) (2022)
David Busse, Philipp Simon, Lisa Schmitt, David Petroff, Christoph Dorn, Arne Dietrich, Markus Zeitlinger, Wilhelm Huisinga, Robin Michelet, Hermann Wrigge, Charlotte Kloft
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients. Clinical pharmacokinetics (2021)
David Busse, Philipp Simon, David Petroff, Christoph Dorn, Lisa Schmitt, Davide Bindellini, Alexander Kratzer, Arne Dietrich, Markus Zeitlinger, Wilhelm Huisinga, Robin Michelet, Hermann Wrigge, Charlotte Kloft
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics. Pharmaceutics 13 (9) (2021)
David Busse, Jens Markus Borghardt, David Petroff, Alice Pevzner, Christoph Dorn, Nahed El-Najjar, Wilhelm Huisinga, Hermann Wrigge, Philipp Simon, Charlotte Kloft
Evaluating prediction methods for glomerular filtration to optimise drug doses in obese and nonobese patients. British journal of clinical pharmacology (2021)
Philipp Simon, David Busse, David Petroff, Christoph Dorn, Lisa Ehmann, Sophie Hochstädt, Felix Girrbach, Arne Dietrich, Markus Zeitlinger, Frieder Kees, Charlotte Kloft, Hermann Wrigge
Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study. Journal of clinical medicine 9 (4) (2020)
Philipp Simon, David Petroff, David Busse, Jana Heyne, Felix Girrbach, Arne Dietrich, Alexander Kratzer, Markus Zeitlinger, Charlotte Kloft, Frieder Kees, Hermann Wrigge, Christoph Dorn
Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients-A Controlled Clinical Trial. Antibiotics (Basel, Switzerland) 9 (12) (2020)